179003-00-0

Basic information

• Product Name: 3-(2-AMinoethyl)benzoic Acid Methyl Ester
• Synonyms: 3-(2-AMinoethyl)benzoic Acid Methyl Ester
• CAS NO: 179003-00-0
• Molecular Formula: C₁₀H₁₃NO₂
• Molecular Weight: 179
• Product Categories: Amines;Aromatics;Miscellaneous Reagents
• Mol File: 179003-00-0.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 293.816 °C at 760 mmHg
• Flash Point: 150.518 °C
• Appearance: /
• Density: 1.094 g/cm³
• CAS DataBase Reference: 3-(2-AMinoethyl)benzoic Acid Methyl Ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2-AMinoethyl)benzoic Acid Methyl Ester(179003-00-0)
• EPA Substance Registry System: 3-(2-AMinoethyl)benzoic Acid Methyl Ester(179003-00-0)

Safety Data

• Hazardous Substances Data: 179003-00-0(Hazardous Substances Data)

Usage

General Description

3-(2-Aminoethyl)benzoic acid methyl ester, also known as Etacidocaine, is a chemical compound with the molecular formula C10H13NO2. It is a derivative of benzoic acid and is commonly used as a local anesthetic. 3-(2-Aminoethyl)benzoic acid methyl ester has a numbing effect on the skin and mucous membranes, making it effective for use in medical and dental procedures. It works by blocking the transmission of pain signals from the nerves to the brain. This chemical is often found in topical anesthetic creams and gels, and is used to provide relief from minor skin irritations, sunburn, and insect bites. It is important to use this compound under the guidance of a healthcare professional to ensure proper dosage and safety.

Upstream product

• 68432-92-8 methyl 3-cyanomethylbenzoate 
• 99-36-5 1-methoxycarbonyl-3-methylbenzene 
• 1129-28-8 3-methoxycarbonylbenzyl bromide 
• 67-56-1 methanol 

Downstream Products

• 199535-04-1 3-(2-Acetylamino-ethyl)-benzoic acid methyl ester 
• 467439-05-0 3-(2-{(R)-2-[(S)-2-((S)-4-Carboxy-2-isobutoxycarbonylamino-butyrylamino)-4-methyl-pentanoylamino]-3-mercapto-propionylamino}-ethyl)-benzoic acid methyl ester 
• 141029-23-4 3-(2-{[(tert-butoxy)carbonyl]amino}ethyl)benzoic acid 
• 179003-02-2 methyl 3-(2-{[(tert-butoxy)carbonyl]amino}ethyl)benzoate 
• 1093938-76-1 methyl 3-(2-(tert-butoxycarbonyl(methyl)amino)ethyl)benzoate 
• 1093938-04-5 methyl 3-(2-(methylamino)ethyl)benzoate 

Relevant articles and documents

THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

The disclosure relates to inhibitors of USP28 and/or USP25 useful in the treatment of cancers, inflammation, autoimmune diseases, and infectious diseases, having the Formula (I), where R1, R2, R3, R4, R5, R5', R6, R7, X, m, and n are described herein.

HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF

The present invention includes surprisingly water-soluble salts of a phenylalkylamine compound that are potent antagonists of L-type calcium channels. Aqueous solutions including salts of the instant invention are formulated for nasal administration and provide a novel therapeutic platform for the treatment of stable angina, migraine, and cardiac arrhythmia, such as paroxysmal supraventricular tachycardia.

Phenethyl amides as novel noncovalent inhibitors of hepatitis C virus NS3/4A protease: Discovery, initial SAR, and molecular modeling

The discovery of novel, reversible and competitive tripeptide inhibitors of the Hepatitis C virus NS3/4A serine protease is described. These inhibitors are characterized by the presence of a C-terminal phenethyl amide group, which extends into the prime side of the enzyme. Initial SAR together with molecular modeling and data from site-directed mutagenesis suggest an interaction of the phenethyl amide group with Lys-136.